Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07572591 · ClinicalTrials.gov registry record · NA
Ultrasound for Peripheral Nerve Modulation
A NA study, sponsored by Stanford University.
- Not yet
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT07572591: Clinical Trial NA study, sponsored by Stanford University.
NCT07572591 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07572591, a NA study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
This study evaluates an ultrasound device designed to reduce pain by targeting peripheral nerves without surgery or medication. The device is placed on the skin over the area of pain and delivers controlled ultrasound stimulation. Adults with nerve-related pain will participate in a single study visit that includes stimulation sessions and pain assessments. The goal of this study is to determine whether non-invasive ultrasound can safely and effectively reduce pain and to assess whether this approach is practical for future clinical use.
Primary Outcome
Assessment of the number and severity of device- and procedure-related adverse events associated with focused ultrasound neuromodulation. Events will be graded according to standard clinical criteria, including pain, skin irritation, thermal effects, or neurologic symptoms.
Interventions
- DEVICE Ultrasound
- DEVICE Sham (No Treatment)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2026-06 |
| Est. Completion | 2027-06 |
| Phase | NA |
What is known before NCT07572591 opens enrollment
NCT07572591 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Ultrasound is the first listed.
NCT07572591 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07572591 about?
NCT07572591 is a clinical study titled "Ultrasound for Peripheral Nerve Modulation". This study evaluates an ultrasound device designed to reduce pain by targeting peripheral nerves without surgery or medication. The device is placed on the skin over the area of pain and delivers controlled ultrasound stimulation. Adults with nerve-related pain will participate in a single study vi...
What is the current status of trial NCT07572591?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2026-06. Estimated completion is 2027-06.
What interventions are being tested in trial NCT07572591?
The interventions under investigation include: Ultrasound (DEVICE), Sham (No Treatment) (DEVICE).
Who is sponsoring clinical trial NCT07572591?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07572591's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia